Comparative regulation of α1-adrenergic receptor mediated contraction in urogenitally derived smooth muscleEffect of epidermal growth factor

被引:0
作者
F. J. Pereira
P. Drescher
D. Rauch
P. O. Madsen
J. A. Will
机构
[1] University of Wisconsin,
来源
Urological Research | 1997年 / 25卷
关键词
Smooth muscle tone; EGF; -Adrenoceptor-mediated contraction; Benign prostatic hyperplasia;
D O I
暂无
中图分类号
学科分类号
摘要
Contractility of smooth muscle within mammalian urogenital organ systems has an established role in physiological/pathophysiological functioning of the component structures. Our aim was to examine the direct effect of epidermal growth factor (EGF) on smooth muscle tone as well as its indirect effects in regulatingα1-adrenoceptor-mediated contraction of the prostate, the vas deferens and renal arteries. Tissues were mounted isometrically, under controlled conditions, and changes in tension in response to treatment with phenylephrine (PE) with or without pretreatment with EGF were recorded on a physiological recorder via force transducers. In the rabbit prostate, EGF potentiated the magnitude of contraction to PE. The potentiation appeared to be dependent on cyclo-oxygenase products. In the human prostate, EGF potentiated the contractile response to PE. EGF had no effect on the PE-induced contraction of the rabbit renal artery and vas deferens. EGF alone did not alter smooth muscle tone in any of the above-mentioned tissues. The main finding of this study is the difference in the regulation by EGF of theα1-adrenoceptor-mediated response in smooth muscle of the prostate, from that by the vas deferens and renal artery. The reasons for this difference in response remain to be elucidated. This study may form the basis for further investigation into receptor transregulation and its relevance to symptomatic benign prostatic hyperplasia (BPH).
引用
收藏
页码:S13 / S19
相关论文
共 109 条
  • [1] Aumuller G(1989)Morphologic and regulatory aspected of prostatic function Anat Embryol Berl 179 519-undefined
  • [2] Blaivas JG(1988)Pathophysiology and differential diagnosis of benign prostatic hypertrophy Urology 32 5-undefined
  • [3] Bouthillier J(1987)Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo Br J Pharmacol 92 257-undefined
  • [4] de Blois D(1974)Epidermal growth factor: effects of androgens and adrenergic agents Endocrinology 95 776-undefined
  • [5] Marceau F(1982)Epidermal growth factor stimulates prostaglandin E release from isolated perfused rat stomach Biochem Biophys Res Commun 105 370-undefined
  • [6] Byyny RL(1991)Pulse exposure to protein synthesis inhibitors enhances tissue response to desArg9-bradykinin: possible role of interleukin-1 Br J Pharmacol 103 1057-undefined
  • [7] Orth DN(1993)Alphas receptor mediated smooth muscle regulation in benign prostatic hyperplasia Scand J Nephrol (Suppl) 157 33-undefined
  • [8] Cohen S(1993)Role of intracellular Ca Urol Res 21 319-undefined
  • [9] Doyne ES(1994) stores in smooth muscle stores in smooth muscle contractions of the guinea pig vas deferens Urol Res 22 143-undefined
  • [10] Chiba T(1989)G-Proteins in alpha J Clin Endocrinol Metab 68 740-undefined